European Journal of Human Genetics
@ejhg_journal
Followers
8K
Following
1K
Media
21
Statuses
4K
The official journal of the European Society of Human Genetics, providing insights into human genetics, genomics, molecular, clinical and cytogenetics research
London, England
Joined November 2018
The December issue of #EJHG is online! New genes, new discoveries, new insights in #HumanGenetics
https://t.co/FIkYY67zw6
0
7
26
New insights into DLG3 variants reveal a broader, syndromic spectrum of X-linked Intellectual Developmental Disorder 90. #Genetics #RareDisease #Neurodevelopment
https://t.co/WTjuumBv93
nature.com
European Journal of Human Genetics - Further phenotypical delineation of DLG3-related neurodevelopmental disorders
0
1
2
Whole-exome sequencing in 506 patients with #InheritedRetinalDisease shows approximately 50% diagnostic yield. Early onset & family history boost detection, while heterogeneous diseases remain challenging. #Genetics #PrecisionMedicine
https://t.co/33prkGeUqX
nature.com
European Journal of Human Genetics - Determinants of diagnostic yield in a multi-ethnic Asian inherited retinal disease cohort
0
4
14
Whole-exome sequencing in 506 patients with #InheritedRetinalDisease shows approximately 50% diagnostic yield. Early onset & family history boost detection, while heterogeneous diseases remain challenging. #Genetics #PrecisionMedicine
https://t.co/33prkGeUqX
nature.com
European Journal of Human Genetics - Determinants of diagnostic yield in a multi-ethnic Asian inherited retinal disease cohort
0
4
14
Fragile X without the repeat expansion? A rare FMR1 missense variant (p.Gln167Pro) may cause #FragileX features. https://t.co/QGuftB4DJF
nature.com
European Journal of Human Genetics - A missense variant in the KH0-domain of FMRP downregulates the protein in a patient with the clinical hallmarks of fragile X syndrome
0
3
18
Fragile X without the repeat expansion? A rare FMR1 missense variant (p.Gln167Pro) may cause #FragileX features. https://t.co/QGuftB4DJF
nature.com
European Journal of Human Genetics - A missense variant in the KH0-domain of FMRP downregulates the protein in a patient with the clinical hallmarks of fragile X syndrome
0
3
18
How do patients feel about genomic testing in primary care? Are we ready for genomic medicine at the frontline? #Genomics #PrimaryCare #PatientExperience
https://t.co/FK7TG8PEEO
nature.com
European Journal of Human Genetics - A systematic review of consumers’ knowledge, attitudes and experiences of primary health professionals’ role in genomic medicine
0
3
4
How do patients feel about genomic testing in primary care? Are we ready for genomic medicine at the frontline? #Genomics #PrimaryCare #PatientExperience
https://t.co/FK7TG8PEEO
nature.com
European Journal of Human Genetics - A systematic review of consumers’ knowledge, attitudes and experiences of primary health professionals’ role in genomic medicine
0
3
4
The December issue of #EJHG is online! New genes, new discoveries, new insights in #HumanGenetics
https://t.co/FIkYY67zw6
0
7
26
Welcome to this month’s #JournalClub! We’re discussing: “Further delineation of defects in MRPS2 causing human OXPHOS deficiency and early developmental abnormalities in zebrafish” from the November issue of #EJHG
https://t.co/9f7rDxMXuK
1
9
12
These findings broaden the genotypic and phenotypic spectrum of MRPS2-related disease, validate pathogenicity using both in vitro and in vivo models, and highlight the crucial role of MRPS2 for mitochondrial and early developmental function.
0
0
0
Additionally, zebrafish F0 knockouts using CRISPR/Cas9 technology were generated to study MRPS2 function during early development. Destabilization of the mitoribosome, developmental abnormalities, and reduced OXPHOS activity in knockout larvae compared to controls were observed.
1
0
0
In these cells, reduced MRPS2 expression and impaired OXPHOS complex activity were found along with altered mitochondrial morphology.
1
0
0
Exome sequencing was used to identify novel variants, followed by functional studies and proteomics to study patient-derived fibroblasts with MRPS2 variants.
1
0
0
MRPS2 encodes a key mito-ribosomal protein essential for mitochondrial translation, with defects leading to combined OXPHOS deficiency and variable clinical phenotypes.
1
0
0
Welcome to this month’s #JournalClub! We’re discussing: “Further delineation of defects in MRPS2 causing human OXPHOS deficiency and early developmental abnormalities in zebrafish” from the November issue of #EJHG
https://t.co/9f7rDxMXuK
1
9
12
#AltmetricChampion of the November issue! Most discussed paper of this month: "Genomic sequencing technologies for rare disease in mainstream healthcare: the current state of implementation."
Genomic testing is expanding across mainstream healthcare, but how well is it being implemented? This comprehensive review explores what works, what varies, and what still needs transformation. https://t.co/joipEPwtjv
0
1
1
#AltmetricChampion of the November issue! Most discussed paper of this month: "Genomic sequencing technologies for rare disease in mainstream healthcare: the current state of implementation."
Genomic testing is expanding across mainstream healthcare, but how well is it being implemented? This comprehensive review explores what works, what varies, and what still needs transformation. https://t.co/joipEPwtjv
0
1
1
Analysis of 462 PcG/TrxG patients reveals gene- and patient-level phenotypic clusters that don’t always align with genetic diagnoses, highlighting both convergence and heterogeneity in these rare disorders. #RareDisease #Epigenetics #PcG #TrxG
https://t.co/d8x0tJKzfX
nature.com
European Journal of Human Genetics - Polycomb-associated and Trithorax-associated developmental conditions—phenotypic convergence and heterogeneity
0
1
2
Genomic testing is expanding across mainstream healthcare, but how well is it being implemented? This comprehensive review explores what works, what varies, and what still needs transformation. https://t.co/joipEPwtjv
nature.com
European Journal of Human Genetics - Genomic sequencing technologies for rare disease in mainstream healthcare: the current state of implementation
1
10
25